Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Michael A. Mancano"'
Publikováno v:
Hospital Pharmacy. 54:88-92
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA) MedWatch program (800-FDA-1088). If you have
Publikováno v:
Hospital Pharmacy. 53:371-375
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA) MedWatch program (800-FDA-1088). If you have
Autor:
Michael A. Mancano
Publikováno v:
Hospital Pharmacy. 52:330-333
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA) MedWatch program (800-FDA-1088). If you have
Autor:
Michael A. Mancano
Publikováno v:
Hospital Pharmacy. 52:253-257
Autor:
Michael A. Mancano
Publikováno v:
Hospital Pharmacy. 52:172-176
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have
Autor:
Michael A. Mancano
Publikováno v:
Hospital Pharmacy. 52:94-97
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have
Autor:
Michael A. Mancano
Publikováno v:
Hospital Pharmacy. 52:13-16
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have
Autor:
Michael A. Mancano
Publikováno v:
Hospital Pharmacy. 53:220-222
Autor:
Michael A. Mancano
Publikováno v:
Hospital Pharmacy. 53:93-95
Publikováno v:
Hosp Pharm
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration’s (FDA) MedWatch program (800-FDA-1088). If you have